Literature DB >> 7784275

Parkinson's disease.

D Mukherjee1, I R Hastie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7784275      PMCID： PMC2398088          DOI： 10.1136/pgmj.71.834.201

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  23 in total

Review 1.  New selective COMT inhibitors: useful adjuncts for Parkinson's disease?

Authors:  P T Männistö; S Kaakkola
Journal:  Trends Pharmacol Sci       Date:  1989-02       Impact factor: 14.819

2.  Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up.

Authors:  O Lindvall; S Rehncrona; P Brundin; B Gustavii; B Astedt; H Widner; T Lindholm; A Björklund; K L Leenders; J C Rothwell; R Frackowiak; D Marsden; B Johnels; G Steg; R Freedman; B J Hoffer; A Seiger; M Bygdeman; I Strömberg; L Olson
Journal:  Arch Neurol       Date:  1989-06

3.  Clinical and pathological aspects of parkinsonism in Alzheimer's disease. A role for extranigral factors?

Authors:  J C Morris; M Drazner; K Fulling; E A Grant; J Goldring
Journal:  Arch Neurol       Date:  1989-06

4.  Transplantation of fetal substantia nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson's disease.

Authors: 
Journal:  N Engl J Med       Date:  1988-08-11       Impact factor: 91.245

5.  Subcutaneous apomorphine in parkinsonian on-off oscillations.

Authors:  C M Stibe; A J Lees; P A Kempster; G M Stern
Journal:  Lancet       Date:  1988-02-20       Impact factor: 79.321

6.  The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport.

Authors:  J G Nutt; W R Woodward; J P Hammerstad; J H Carter; J L Anderson
Journal:  N Engl J Med       Date:  1984-02-23       Impact factor: 91.245

7.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

8.  Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.

Authors:  J W Langston; P Ballard; J W Tetrud; I Irwin
Journal:  Science       Date:  1983-02-25       Impact factor: 47.728

9.  Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases.

Authors:  P A Ballard; J W Tetrud; J W Langston
Journal:  Neurology       Date:  1985-07       Impact factor: 9.910

10.  Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease.

Authors:  D D Spencer; R J Robbins; F Naftolin; K L Marek; T Vollmer; C Leranth; R H Roth; L H Price; A Gjedde; B S Bunney
Journal:  N Engl J Med       Date:  1992-11-26       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.